Skip to main content
. 2013 Jul 8;110(27-28):468–476. doi: 10.3238/arztebl.2013.0468

Table 4. Endpoints in 13 randomized trials comparing CAS and CEA*1.

Endpoints Number of patients*2 Number of trials*2 CAS CEA Absolute risk difference (CAS versus CEA) Pooled odds ratio(95% confidence interval)
Any periprocedural stroke or death 7390 12 6.7% 4.4% + 2.3% 1.54 (1.25–1.89)
Any periprocedural stroke 7171 11 6.0% 3.9% + 2.1% 1.53 (1.23–1.91)
Any stroke (mean follow-up 2.7 years) 5359 9 10.8% 8.2% + 2.6% 1.37 (1.13–1.65)
Periprocedural myocardial infarction 5952 9 0.8% 1.7% – 0.9% 0.48 (0.29–0.78)
Periprocedural cranial nerve dysfunction 6062 11 0.3% 5.4% – 5.1% 0.09 (0.05–0.16)

*1Modified from (30)

*2Number of patients and trials in which the endpoint in question was used CAS, carotid stenting; CEA, carotid endarterectomy